Work

AG-221 offers a survival advantage in a primary human IDH2 mutant AML xenograft model

Year: 2015

Type: conference-abstract

Source: Annals of Oncology

DOI: 10.1093/annonc/mdv089.2

Authors: K. Yen, F. Wang, J. Travins, Y. Chen, H. Yang, K. Straley, S. Choe, M. Dorsch, S. Agresta, D. Schenkein, S. Biller, M. Su

Institution: Agios Pharmaceuticals (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W1964919610

Cites:

Cited by: 2

Related to: 10